Molecular cloning, over expression, and activity studies of a peptidic HIV-1 protease inhibitor: Designed synthetic gene to functional recombinant peptide

Peptides

Volumn 31, Issue 1, 2010, Pages 16-21

  Vathipadiekal, Vinod ^a   Umasankar, Perunthottathu K ^b   Patole, Milind S ^b   Rao, Mala ^a  

^a NATIONAL CHEMICAL LABORATORY   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Gateway cloning; HIV 1 protease; Inhibitor; Proteases; Synthetic gene

Indexed keywords

AMINO ACID DERIVATIVE; ARABINOSE; ASPARTIC PROTEINASE; ASPARTIC PROTEINASE INHIBITOR; BLOOD CLOTTING FACTOR 10A; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; OLIGONUCLEOTIDE; PEPSIN A; PROTEINASE; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL CELL; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG DESIGN; DRUG PURIFICATION; ESCHERICHIA COLI; GENE OVEREXPRESSION; MASS SPECTROMETRY; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

CLONING, MOLECULAR; GLUTATHIONE TRANSFERASE; HIV PROTEASE; OLIGOPEPTIDES; PEPTIDES; RECOMBINANT PROTEINS;

BACILLUS SP.; ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 72749102190     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.09.034     Document Type: Article

References (33)

1. Abu-Erreish G.B., and Peanasky R.J. Pepsin inhibitors from Ascaris lumbricoides. Isolation, purification, and some properties. J Biol Chem 249 (1974) 1558-1565
2. Brandwijk RJMGE, Nesmelova I., Dings R.P.M., Mayo K.H., Thijssen V.L.G.L., and Griffioen A.J. Cloning an artificial gene encoding angiostatic anginex: from designed peptide to functional recombinant protein. Biochem Biophys Res Commun 333 (2005) 1261-1268
3. Breugelmans B., Simonet G., Hoef V.V., Soest S.V., Smagghe G., and Broeck J.V. A lepidopteran pacifastin member: cloning, gene structure, recombinant production, transcript profiling and in vitro activity. Insect Biochem Mol Biol 39 (2009) 430-439
4. Callaway J.E., Lai J., Haselbeck B., Baltaian M., Bonnesen S.P., Weickmann J., et al. Modification of the C terminus of cecropin is essential for broad-spectrum antimicrobial activity. Antimicrob Agents Chemother 37 (1993) 1614-1619
5. Cater S.A., Lees W.E., Hill J., Brzin J., Kay J., and Phylip L.H. Aspartic proteinase inhibitors from tomato and potato are more potent against yeast proteinase A than cathepsin D. Biochim Biophys Acta 1596 (2002) 76-82
6. Christeller J.T., Farley P.C., Ramsay R.J., Sullivan P.A., and Laing W.A. Purification, characterization and cloning of an aspartic proteinase inhibitor from squash phloem exudates. Eur J Biochem 254 (1998) 160-167
7. Dash C., Ahmad A., Nath D., and Rao M. Novel bifunctional inhibitor of xylanase and aspartic protease: implications for inhibition of fungal growth. Antimicrob Agents Chemother 45 (2001) 2008-2017
8. Dash C., Phadtare S., Deshpande V., and Rao M. Structural and mechanistic insight into the inhibition of aspartic proteases by a slow-tight binding inhibitor from an extremophilic Bacillus sp.: correlation of the kinetic parameters with the inhibitor induced conformational changes. Biochemistry 40 (2001) 11525-11532
9. Dash C., and Rao M. Interactions of a novel inhibitor from an extremophilic Bacillus sp. with HIV-1 protease: implications for the mechanism of inactivation. J Biol Chem 276 (2001) 2487-2493
10. Dash C., Vathipadiekal V., George S.P., and Rao M. Slow-tight binding inhibition of xylanase by an aspartic protease inhibitor: kinetic parameters and conformational changes that determine the affinity and selectivity of the bifunctional nature of the inhibitor. J Biol Chem 277 (2002) 17978-17986
11. Galleschi L., Friggeri M., Repiccioli R., and Come D. Aspartic proteinase inhibitor from wheat: some properties. Proceedings of the fourth international workshop on seeds. Angers, France (1993) 207-211
12. Gavit P., and Better M. Production of antifungal recombinant peptides in Escherichia coli. J Biotechnol 79 (2000) 127-136
13. Georgiou G. Expression of proteins in bacteria. In: Cleland J.L., and Craik C.S. (Eds). Protein engineering: principles and practice (1996), Wiley-Liss, New York 101-127
14. Howell M.L., and Blumenthal K.M. Cloning and expression of a synthetic gene for Cerebratulus lacteus neurotoxin B-IV. J Biol Chem 264 (1989) 15268-15273
15. James M.N.G. Aspartic proteinases: retroviral and cellular enzymes (1998), Plenum Press, NY
16. Kageyama T. Molecular cloning, expression and characterization of an Ascaris inhibitor for pepsin and cathepsin E. Eur J Biochem 253 (1998) 804-809
17. Keilova H., and Tomasek V. Isolation and some properties of cathepsin D inhibitor from potatoes. Collect Czech Chem Commun 41 (1976) 489-497
18. Kelly W.S. Therapeutic peptides: the devil is in the details. Bio/Technology 14 (1996) 28-31
19. Lenarcic B., and Turk V. Thyroglobulin type-1 domains in equistatin inhibit both papain-like cysteine proteinases and cathepsin D. J Biol Chem 274 (1999) 563-566
20. Li M., Li L.-Y., Wu X., and Liang S.-P. Cloning and functional expression of a synthetic gene encoding Huwentoxin-I, a neurotoxin from the Chinese bird spider (Selenocosmia huwena). Toxicon 38 (2000) 153-162
21. Maere V.D., Vercauteran I., Gevaert K., Vercruysse J., and Claerebout E. An aspartyl protease inhibitor of Ostertagia ostertagi: molecular cloning, analysis of stage and tissue specific expression and vaccine trial. Mol Biochem Parasitol 141 (2005) 81-88
22. Mares M., Meloun B., Pavlik M., Kostka V., and Baudys M. Primary structure of cathepsin D inhibitor from potatoes and its structure relationship to soybean trypsin inhibitor family. FEBS Lett 251 (1989) 94-98
23. Ng K.K.S., Petersen J.F.W., Cherney M.M., Garen C., Zalatoris J.J., Rao-Naik C., et al. Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3. Nat Struct Biol 7 (2000) 653-657
24. Phylip L.H., Lees W.E., Brownsey B.G., Bur D., Dunn B.M., Winther J.R., et al. The potency and specificity of the interaction between the IA3 inhibitor and its target aspartic proteinase from Saccharomyces cerevisiae. J Biol Chem 276 (2001) 2023-2030
25. Phylip L.H., Richards A.D., Kay J., Konvolinka J., Strap P., Blaha I., et al. Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases. Biochem Biophys Res Commun 171 (1990) 439-444
26. Piers K.L., Brown M.H., and Hancock R.E.W. Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene 134 (1993) 7-13
27. Richards A.D., Phylip L.H., Farmerie W.G., Scarborough P.E., Alvarez A., Dunn B.M., et al. Sensitive, soluble chromogenic substrates for HIV-1 proteinase. J Biol Chem 265 (1990) 7733-7736
28. Rudolph R. Successful protein folding on an industrial scale. In: Cleland J.L., and Craik C.S. (Eds). Protein engineering: principles and practice (1996), Wiley-Liss, New York 283-298
29. Schu P., and Wolf D.H. The proteinase yscA-inhibitor, IA3, gene studies of cytoplasmic proteinase inhibitor deficiency on yeast physiology. FEBS Lett 283 (1991) 78-84
30. Simonet G., Claeys I., Huybrechts J., Loof A.D., and Broeck J.V. Bacterial production and purification of SGP-1 and SGP-2, two peptidic serine protease inhibitors from the desert locust, Schistocerca gregaria. Protein Expr Purif 31 (2003) 188-196
31. Smith D.B., and Johnson K.S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67 (1988) 31-40
32. Stewart K., Goldman R.C., and Abad-Zapatero C. The secreted proteinases from Candida: challenges for structure aided drug design. In: Dunn B.M. (Ed). Proteases of infectious agents (1999), Academic Press, San Diego, CA 117-138
33. Wong S.L. Advances in the use of Bacillus subtilis for the expression and secretion of heterologous proteins. Curr Opin Biotechnol 6 (1995) 517-522